1. Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis

   • Sang Hyun Choi
   • Seung Chai Jung
   • Ho Sung Kim

   Topic Review 23 April 2016 Pages: 185 - 194

   

2. Cognitive functioning in meningioma patients: a systematic review

   • Ikram Meskal
   • Karin Gehring
   • Margriet M. Sitskoorn

   Topic Review Open access 05 April 2016 Pages: 195 - 205

3. Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma

   • Andrew W. Smith
   • Minesh P. Mehta
   • A. Gabriella Wernicke

   Topic Review 23 April 2016 Pages: 207 - 216

   

4. Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species

   • Yuanyuan Liu
   • Chenghe Fan
   • Yining Huang

   Laboratory Investigation 16 March 2016 Pages: 217 - 223

   

5. A preclinical murine model for the early detection of radiation-induced brain injury using magnetic resonance imaging and behavioral tests for learning and memory: with applications for the evaluation of possible stem cell imaging agents and therapies

   • Ethel J. Ngen
   • Lee Wang
   • Dmitri Artemov

   Laboratory Investigation 28 March 2016 Pages: 225 - 233

   

6. Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?

   • E. Franceschi
   • M. Bartolotti
   • A. A. Brandes

   Clinical Study 03 March 2016 Pages: 235 - 240

   

7. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma

   • Ryan Rhome
   • Rebecca Fisher
   • Rahul R. Parikh

   Clinical Study 12 March 2016 Pages: 241 - 250

   

8. Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery

   • Zabi Wardak
   • Alexander Augustyn
   • Kevin S. Choe

   Clinical Study 10 March 2016 Pages: 251 - 257

   

9. A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy

   • Jiayi Huang
   • Jian L. Campian
   • Albert H. Kim

   Clinical Study 10 March 2016 Pages: 259 - 266

   

10. Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus

    • Hiromitsu Iwata
    • Kengo Sato
    • Yuta Shibamoto

    Clinical Study 09 March 2016 Pages: 267 - 275

    

11. Predictors of survival for patients with cancer after cryptogenic stroke

    • Yong-Won Shin
    • Soon-Tae Lee
    • Sang Kun Lee

    Clinical Study 11 March 2016 Pages: 277 - 284

    

12. Seizures in patients with primary brain tumors: what is their psychosocial impact?

    • John Y. Shin
    • Sani H. Kizilbash
    • Aminah Jatoi

    Clinical Study 15 March 2016 Pages: 285 - 291

13. Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation

    • Andrew J. Dodgshun
    • Nadine SantaCruz
    • Pratiti Bandopadhayay

    Clinical Study 19 March 2016 Pages: 293 - 302

    

14. Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?

    • Michela Buglione
    • Sara Pedretti
    • Stefano Maria Magrini

    Clinical Study 30 March 2016 Pages: 303 - 312

    

15. Executive dysfunction is associated with poorer health-related quality of life in pediatric brain tumor survivors

    • Kelli L. Netson
    • Jason M. Ashford
    • Heather M. Conklin

    Clinical Study 31 March 2016 Pages: 313 - 321

    

16. Neurocognitive functioning in patients with glioma of the left and right temporal lobes

    • Kyle R. Noll
    • Mateo Ziu
    • Jeffrey S. Wefel

    Clinical Study 29 March 2016 Pages: 323 - 331

    

17. Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma

    • Giovanni Brigliadori
    • Flavia Foca
    • Marina Faedi

    Clinical Study 30 March 2016 Pages: 333 - 339

    

18. Radiotherapy plus concomitant temozolomide in primary gliosarcoma

    • Sebastian Adeberg
    • Denise Bernhardt
    • Juergen Debus

    Clinical Study 30 March 2016 Pages: 341 - 348

    

19. Clinical features and prognostic factors of WHO II and III adult spinal meningiomas: analysis of 25 cases in a single center

    • Jingliang Ye
    • Guoguang Lv
    • Chun Luo

    Clinical Study 07 April 2016 Pages: 349 - 356

    

20. Parameters influencing local control of meningiomas treated with radiosurgery

    • Tania Kaprealian
    • David R. Raleigh
    • Michael W. McDermott

    Clinical Study 30 April 2016 Pages: 357 - 364

21. Regional disparities in hospitalization charges for patients undergoing craniotomy for tumor resection in New York State: correlation with outcomes

    • Symeon Missios
    • Kimon Bekelis

    Clinical Study 12 April 2016 Pages: 365 - 371

    

22. Diffuse astrocytoma arising within a demyelinating plaque

    • David Ryan Ormond
    • B. K. Kleinschmidt-DeMasters

    Letter to the Editor 31 March 2016 Pages: 373 - 375